Trial Profile
Clinical Trials Insight: 700022168
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2007
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Apr 2007 New trial record.